Everest Organics informs about press release

12 Oct 2021 Evaluate
Everest Organics has informed that it enclosed the Press Release for successful development of 'Molnupiravir' API, an additional COVID 19 treatment drug for patients with mild and moderate symptoms. 

The above information is a part of company’s filings submitted to BSE.

Everest Organics Share Price

272.00 12.75 (4.92%)
03-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...